Nebojsa M Lalic
Overview
Explore the profile of Nebojsa M Lalic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milicic T, Jotic A, Lalic K, Lukic L, Macesic M, Stanarcic Gajovic J, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004639
: Previous studies reported impairments in insulin secretion during different stages of type 1 diabetes (T1D), while data regarding insulin sensitivity and immunological changes are still controversial. We analyzed the...
2.
Milicic T, Jotic A, Markovic I, Popadic D, Lalic K, Uskokovic V, et al.
J Med Biochem
. 2025 Jan;
43(6):915-926.
PMID: 39876913
Background: Previous studies suggested an important role of impairments in T cell subsets in different stages during type 1 diabetes (T1D) development, while data regarding CD25high T cells and transforming...
3.
Lalic N, Jotic A, Lukic L, Milicic T, Macesic M, Stanarcic Gajovic J, et al.
Diabetes Res Clin Pract
. 2024 Aug;
216:111816.
PMID: 39147102
Aims: This systematic review was aimed to assess the association between magnitude of body weight loss (BWL) in type 2 diabetes (T2D) patients and cardiovascular (CV) risk in CV outcome...
4.
Lalic K, Popovic L, Singh Lukac S, Rasulic I, Petakov A, Krstic M, et al.
Diabetes Res Clin Pract
. 2024 Aug;
215:111819.
PMID: 39128565
Type 2 diabetes (T2D) is associated with increased risk for chronic kidney disease (CKD). It is estimated that 40 % of people with diabetes have CKD, which consequently leads to...
5.
Jotic A, Stoiljkovic M, Milicic T, Lalic K, Lukic L, Macesic M, et al.
Diabetes Ther
. 2023 Mar;
14(5):857-867.
PMID: 36930455
Introduction: Previous gestational diabetes (pGD) is associated with a high risk of postpartum dyslipidemia (pD). Our study was aimed at investigating the prevalence of pD and estimating the risk for...
6.
Pavlovic K, Krako Jakovljevic N, Isakovic A, Ivanovic T, Markovic I, Lalic N
Front Pharmacol
. 2022 Jul;
13:930308.
PMID: 35873556
Metformin is an oral antidiabetic agent that has been widely used in clinical practice for over 60 years, and is currently the most prescribed antidiabetic drug worldwide. However, the molecular...
7.
Isajev N, Bjegovic-Mikanovic V, Bukumiric Z, Vrhovac D, Lalic N
Int J Environ Res Public Health
. 2022 Apr;
19(8).
PMID: 35457303
With the growing prevalence and complex pathophysiology of type 2 diabetes, many patients fail to achieve treatment goals despite guidelines and possibilities for treatment individualization. One of the identified root...
8.
Pesta D, Jelenik T, Zaharia O, Bobrov P, Gorgens S, Bodis K, et al.
Front Endocrinol (Lausanne)
. 2021 Oct;
12:693683.
PMID: 34659107
Clinical Trial Registration: ClinicalTrials.gov, identifier NCT01055093. The trial was retrospectively registered on 25 of January 2010.
9.
Krako Jakovljevic N, Pavlovic K, Zujovic T, Kravic-Stevovic T, Jotic A, Markovic I, et al.
Mitochondrion
. 2021 Oct;
61:165-173.
PMID: 34634496
Mitochondrial dysfunction in diabetes is a widely studied topic, but inconsistency in literature data suggests a need for valid and reproducible models that will help to clarify this interaction. We...
10.
Jotic A, Stoiljkovic M, Milicic T, Lalic K, Lukic L, Macesic M, et al.
Diabetes Ther
. 2021 Aug;
12(10):2691-2700.
PMID: 34458964
Introduction: Women with previous gestational diabetes (pGD) are at higher risk of prediabetes (PD) after delivery. The aim of this study was to determine the prevalence of and predictors for...